Overcoming Poor Solubility of Dimenhydrinate: Development, Optimization and Evaluation of Fast Dissolving Oral Film
Purpose: To develop fast dissolving oral film to address vomiting and nausea in pediatric population. Methods: Oral films of Dimenhydrinate were prepared by solvent casting method by using hydroxypropylmethyl cellulose E5 (HPMC E5), polyethylene glycol 400 (PEG 400) and croscarmellose sodium. Solubi...
Saved in:
Main Authors: | , , |
---|---|
Format: | Book |
Published: |
Tabriz University of Medical Sciences,
2018-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_01a4f71448df4cfe9343a36d68f7eaef | ||
042 | |a dc | ||
100 | 1 | 0 | |a Yuvraj Govindrao Jadhav |e author |
700 | 1 | 0 | |a Upendra Chandrakant Galgatte |e author |
700 | 1 | 0 | |a Pravin Digambar Chaudhari |e author |
245 | 0 | 0 | |a Overcoming Poor Solubility of Dimenhydrinate: Development, Optimization and Evaluation of Fast Dissolving Oral Film |
260 | |b Tabriz University of Medical Sciences, |c 2018-11-01T00:00:00Z. | ||
500 | |a 2228-5881 | ||
500 | |a 2251-7308 | ||
500 | |a 10.15171/apb.2018.081 | ||
520 | |a Purpose: To develop fast dissolving oral film to address vomiting and nausea in pediatric population. Methods: Oral films of Dimenhydrinate were prepared by solvent casting method by using hydroxypropylmethyl cellulose E5 (HPMC E5), polyethylene glycol 400 (PEG 400) and croscarmellose sodium. Solubility of dimenhydrinate was enhanced by ethanol as a co-solvent. To make dimenhydrinate palatable sodium saccharin and peppermint oil were used. All films were evaluated for mechanical parameters, surface pH, morphology, disintegration time and percent dissolution. Results: Films were smooth, acceptable and white in colour. For optimized batch, drug content (99.106%), disintegration time (25 sec), dissolution (99.10% in 210 sec), surface pH (6.81) were acceptable. Conclusion: Optimized batch, due to its potential to deliver through fast dissolving film, can be developed for clinical use. | ||
546 | |a EN | ||
690 | |a Antiemetic | ||
690 | |a Dimenhydrinate | ||
690 | |a Fast dissolving film | ||
690 | |a HPMC E5 | ||
690 | |a Superdisintegrants | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Advanced Pharmaceutical Bulletin, Vol 8, Iss 4, Pp 721-725 (2018) | |
787 | 0 | |n https://apb.tbzmed.ac.ir/PDF/APB_17104_20170525193735 | |
787 | 0 | |n https://doaj.org/toc/2228-5881 | |
787 | 0 | |n https://doaj.org/toc/2251-7308 | |
856 | 4 | 1 | |u https://doaj.org/article/01a4f71448df4cfe9343a36d68f7eaef |z Connect to this object online. |